Changes in brain volume 2 years after extracranial-intracranial bypass surgery: A preliminary subanalysis of the Japanese EC-IC trial

Cerebrovasc Dis. 2006;22(2-3):177-82. doi: 10.1159/000093452. Epub 2006 May 19.

Abstract

Background and methods: We studied changes in brain volume on magnetic resonance imaging in 10 patients with and without extracranial-intracranial (EC-IC) bypass surgery who met the inclusion criteria for the Japanese EC-IC Bypass Trial, a multicenter, randomized, prospective study of patients with hemodynamic brain ischemia due to cerebral artery occlusive disease. We also examined the association of cerebral hemodynamics on single-photon emission computed tomography with the changes in brain volume.

Results: The affected/unaffected ratio of the percent brain volume declined in patients without EC-IC bypass surgery (p < 0.02, n = 4), and the affected/unaffected percent regional cerebral blood flow ratio increased in patients with the surgery (p < 0.03, n = 6). Acetazolamide reactivity increased in the affected hemisphere of patients with surgery (p < 0.01). Two-year increase (decrease) in acetazolamide reactivity of the affected hemisphere showed a significant positive correlation with 2-year changes in the affected/unaffected percent brain volume ratio (R2 = 0.737, p = 0.0007).

Conclusions: Change in acetazolamide reactivity might be a good predictor for brain atrophy in cerebral artery occlusive disease.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetazolamide
  • Aged
  • Atrophy
  • Brain / pathology*
  • Brain / physiopathology
  • Brain Ischemia / pathology*
  • Brain Ischemia / physiopathology
  • Brain Ischemia / surgery
  • Cerebral Arterial Diseases / pathology*
  • Cerebral Arterial Diseases / physiopathology
  • Cerebral Arterial Diseases / surgery
  • Cerebral Revascularization*
  • Cerebrovascular Circulation
  • Female
  • Humans
  • Iodine Radioisotopes
  • Japan
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Randomized Controlled Trials as Topic
  • Tomography, Emission-Computed, Single-Photon
  • Treatment Outcome

Substances

  • Iodine Radioisotopes
  • Acetazolamide